-----Original Message-----
From: procaare-bounces@... [mailto:procaare-bounces@...]
On Behalf Of Texas Biotech
Sent: Saturday, May 12, 2007 2:59 PM
To: procaare@...
Subject: [procaare] New Microscopy-based CD4/CD8 test: Affordable
testlaunched

New Microscopy-based CD4/CD8 test: Affordable test launched
*********************

Dear Forum:

A new, simplified, microscopy-based CD4/CD8 test has been approved by the
FDA (under authority of Drug Controller General of India) for wide-scale use
as a diagnostic test. The ImmunoCount test is best suited to monitor ART at
the district and rural settings in developing countries. The validation
studies show that the test has good agreement with flowcytometry
(correlation coefficient r2=0.87) and the technique is now patented.

The test has fewer simple steps and takes 2hr:30min to complete.The
ImmunoCount CD4/CD8 test has a shelf life of 18 months. This test will fill
the unmet need of the field required for expansion of STRUCTURED
Anti-Retroviral Therapy (ART) in resource-limited settings in Asia, Africa,
and South America.

For more details, write to texas.biotech@...

==========================
IMMUNOCOUNT FOR CD4/CD8 testing

APPROVED BY
FDA (Under authority of Drug Controller of India)

SALIENT FEATURES OF THE TEST.
* Effective monitoring of HIV disease progression and ART
* Affordable at significantly lower cost than sophisticated tests. Cost of
equipment at a fraction
* Microscopy-based test, suitable for small labs.
* Can be used with ease in district and rural settings
* CD4 and CD8 counts available on one slide
* Positive and negative controls on each slide
* Validation studies show good agreement with
flowcytometry


A Research Product of the University of Texas-Houston and Mahatma Gandhi
University of Health Sciences, Navi Mumbai (Recognised Centre of Excellence
by the Council of Scientific & Industrial Research, Govt. of India, New
Delhi)

_______________________________________________
Post message: procaare@...
Subscribe: procaare-join@...
Unsubscribe: procaare-leave@...
Help: procaare-owner@...
Info & archives: http://list.healthnet.org/mailman/listinfo/procaare